Last $35.00 USD
Change Today 0.00 / 0.00%
Volume 0.0
OCPNF On Other Exchanges
Symbol
Exchange
Tokyo
OTC US
OTC US
Frankfurt
As of 5:10 PM 07/3/14 All times are local (Market data is delayed by at least 15 minutes).

olympus corp (OCPNF) Snapshot

Open
$35.00
Previous Close
$35.00
Day High
$35.00
Day Low
$35.00
52 Week High
07/3/14 - $35.00
52 Week Low
08/22/13 - $28.35
Market Cap
12.0B
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
342.7M
EX-Date
03/27/14
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OLYMPUS CORP (OCPNF)

Related News

No related news articles were found.

olympus corp (OCPNF) Related Businessweek News

View More BusinessWeek News

olympus corp (OCPNF) Details

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates in five segments: Medical, Life Science and Industrial, Imaging, Information and Communication, and Others. The Medical segment provides endoscopic video imaging, medical information, fiberscope, broncho endoscope, and endoscopic ultrasound systems; ultrasound probes and centers; capsule endoscopy systems; cleaning, disinfecting, and sterilization systems; medical treatment peripherals; and ancillary products. This segment also offers endoscopy products for gastroenterological surgery, thoracic surgery, urology, gynecology, orthopedic surgery, neurosurgery, anesthesiology, and otolaryngology; treatment and surgical equipment; and peripherals, as well as endotherapy products. The Life Science and Industrial segment provides biological products, such as system and system biological microscopes, inverted biological microscopes, stereo and confocal laser scanning microscopes, single-molecule fluorescence detection systems, microscope system equipment, and peripherals; industrial microscope systems, including metallurgical and semiconductor inspection microscopes, flat-panel display inspection systems, laser microscopes, measuring microscopes, microscopic 3-D measurement systems, and peripherals; printers; and remote visual inspection products and non-destructive testing products. The Imaging segment offers digital cameras; optical components comprising lens barrels for digital cameras and optical materials; and IC recorders and binoculars. The Information and Communication segment sells mobile terminals, including mobile handsets. The Others segment manufactures and sells biomedical materials, as well as conducts system development and other business activities. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

30,702 Employees
Last Reported Date: 06/26/14
Founded in 1919

olympus corp (OCPNF) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

olympus corp (OCPNF) Key Developments

Olympus Announces the Introduction of the RollerFORM

Olympus announced the introduction of the RollerFORM, a new ultrasound phased array wheel probe that has been specifically developed to facilitate high-quality, immersion-like ultrasonic testing of composites and other smooth-surfaced materials that are commonly used in the aerospace industry. An affordable and easy-to-implement replacement for full 2-D encoding systems, the RollerFORM also offers a viable alternative to immersion techniques. The RollerFORM's wheel tire is made from a unique material that closely matches the acoustic impedance of water. This design feature permits the efficient transmission of energy to the part without unwanted echoes, obtaining an optimum 1 mm near-surface resolution in composites when using the 5 MHz phased array probe model. The 3.5 MHz probe model is better suited for thicker and more attenuating materials. Since the tire material is transparent, the inspector can easily identify the presence of air bubbles or contaminants within the water chamber. Minimal pressure is required to achieve excellent coupling, ensuring a strong signal even in difficult scanning positions. The RollerFORM in combination with a phased array instrument such as the OmniScan and FOCUS LT flaw detector uses zero-degree ultrasonic beams for the nondestructive testing (NDT) of parts and materials in manufacturing and maintenance environments. Common applications include delamination sizing and quantifying porosity of composite materials, as well as wall-loss monitoring in aluminum panels. With its integrated indexing button, the ergonomically designed RollerFORM enables the inspector to map the surface of a material by acquiring multiple one-line C-scans and combining them in real time into a single image. The built-in laser guide facilitates straight and precise on-line scans. With its lightweight, compact design and durable construction, the RollerFORM wheel probe provides a valued tool in manufacturing and maintenance environments. It is ideal for scanning large areas of composite materials resulting in faster inspection times and increased productivity.

Olympus Corporation Announces to Close its 120-Employee Biotech Manufacturing Plant in West Lebanon, N.H

Olympus Corporation announced that it will close its 120-employee biotech manufacturing plant in West Lebanon, N.H. because it's been unable to find a buyer in the past four months. The company, known for making cameras, announced in February it planned to close a subsidiary, Olympus Biotech, which it started four years ago to focus on products for regenerative medicine. The company purchased the rights to a protein-based putty used to regenerate bones for treating spinal, hip and knee conditions, from Stryker Biotech for $60 million in December 2010.

Olympus Reportedly Planning To Close Plant; Could Not Find Buyer

Olympus Corporation (TSE:7733) could not find a buyer for biotech manufacturing plant in West Lebanon. The company stated that it will close the plant as it's could not find a buyer in the past four months. In February 2014, Olympus Corp announced plans to close down Olympus Biotech Corporation. The company said that the closure was “purely a financial decision and is not related to the performance, quality or safety of our OP-1 family of products.” In an email to the Boston Business Journal on June 17, 2014, Olympus Corp said that “a deal has not been consummated, and therefore Olympus Biotech will continue this closure process, now including the manufacturing location.” All of the biotech's facilities will be closed by August 29, 2014, and the company said that it is offering the 120 employees in New Hampshire "appropriate transition services." Olympus spokesman Mark Miller told the Valley News, “This was a difficult decision and was made only after numerous alternatives for business continuation were identified and exhausted over the past year, including partnerships, acquisitions, private equity, contract manufacturing and other options. None of these came to fruition.”

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCPNF:US $35.00 USD 0.00

OCPNF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Avery Dennison Corp $49.24 USD -1.66
Boston Scientific Corp $13.11 USD -0.15
Hoya Corp ¥3,416 JPY -24.00
Nikon Corp ¥1,591 JPY +11.50
Smith & Nephew PLC 1,057 GBp -9.00
View Industry Companies
 

Industry Analysis

OCPNF

Industry Average

Valuation OCPNF Industry Range
Price/Earnings 90.4x
Price/Sales 1.8x
Price/Book 3.9x
Price/Cash Flow 25.9x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OLYMPUS CORP, please visit www.olympus-global.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.